p-Cresyl sulfate affects the oxidative burst, phagocytosis process, and antigen presentation of monocyte-derived macrophages.

[1]  Toshihide Kobayashi,et al.  p-Cresyl sulfate suppresses lipopolysaccharide-induced anti-bacterial immune responses in murine macrophages in vitro. , 2016, Toxicology letters.

[2]  C. Ronco,et al.  Uremic Toxicity-Induced Eryptosis and Monocyte Modulation: The Erythrophagocytosis as a Novel Pathway to Renal Anemia , 2016, Blood Purification.

[3]  H. Iwata,et al.  Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin , 2014, Clinical and Experimental Nephrology.

[4]  R. Sorrentino,et al.  The Uremic Toxin Indoxyl Sulphate Enhances Macrophage Response to LPS , 2013, PloS one.

[5]  A. Enomoto,et al.  Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats. , 2013, Life sciences.

[6]  W. Hörl,et al.  Immune Dysfunction in Uremia—An Update , 2012, Toxins.

[7]  Raymond Vanholder,et al.  Normal and pathologic concentrations of uremic toxins. , 2012, Journal of the American Society of Nephrology : JASN.

[8]  Keith C. Norris,et al.  Effect of uremia on structure and function of immune system. , 2012, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[9]  Z. Massy,et al.  Warning: the unfortunate end of p-cresol as a uraemic toxin. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  A. Enomoto,et al.  Indoxyl Sulfate Upregulates Expression of ICAM-1 and MCP-1 by Oxidative Stress-Induced NF-ĸB Activation , 2010, American Journal of Nephrology.

[11]  Z. Massy,et al.  Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  N. Vaziri,et al.  Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  H. Krum,et al.  Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? , 2010, European heart journal.

[14]  Pieter Evenepoel,et al.  A review of albumin binding in CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  G. Russ,et al.  Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. , 2007, Kidney international.

[16]  T. Eleftheriadis,et al.  Basic Science and Dialysis: Disturbances of Acquired Immunity in Hemodialysis Patients , 2007, Seminars in dialysis.

[17]  R. Vanholder,et al.  P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  V. Faure,et al.  The uremic solute p-cresol decreases leukocyte transendothelial migration in vitro. , 2006, International immunology.

[19]  C. Ronco,et al.  Reviews: Uremic Toxins: A New Focus on an Old Subject , 2005, Seminars in dialysis.

[20]  P. D. De Deyn,et al.  In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. , 2004, Kidney international.

[21]  R. Vanholder,et al.  The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. , 2004, Kidney international.

[22]  Raymond Vanholder,et al.  Review on uremic toxins: classification, concentration, and interindividual variability. , 2003, Kidney international.

[23]  M. Girndt,et al.  Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. , 2001, Kidney international.

[24]  A. Shore,et al.  Peripheral microvascular parameters in the nephrotic syndrome. , 1998, Kidney international.

[25]  J. Maciejewski,et al.  Non-responsiveness to hepatitis B vaccination in haemodialysis patients: association with impaired TCR/CD3 antigen receptor expression regulating co-stimulatory processes in antigen presentation and recognition. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  W. Hörl,et al.  Uremia and infection: mechanisms of impaired cellular host defense. , 1993, Nephron.

[27]  A. Bellucci,et al.  Mortality in dialysis patients: analysis of the causes of death. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  S. Massry,et al.  Impaired phagocytosis in dialysis patients: studies on mechanisms. , 1991, American journal of nephrology.

[29]  M. Cubellis,et al.  Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate , 1989, The Journal of cell biology.

[30]  E. Lowrie,et al.  Survival of patients undergoing chronic hemodialysis and renal transplantation. , 1973, The New England journal of medicine.

[31]  C. Neuberg,et al.  Simplified Method for the Preparation of Aromatic Sulfuric Acid Esters , 1941 .